NASDAQ
IR-Med Inc. (IRME) has a price/fcf ratio of -23.77x as of Monday, May 25, 2026. This represents a 54.90% increase compared to its 12-month average of -52.71x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.